Skip to main content

Table 3 Geometric mean ratios (week 96 to baseline) and 95% confidence intervals

From: Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results

Biomarker (no. of samples per arm) ABC/3TC + FPV/r ABC/3TC + EFV
hs-CRP 0.99 1.59
 (n = 34, 32) (0.56, 1.74) (0.99, 2.56)
Plasminogen 0.73 0.61*
 (n = 34, 31) (0.52, 1.02) (0.44, 0.85)
sVCAM-1 0.52* 0.58*
 (n = 35, 32) (0.46, 0.58) (0.53, 0.64)
d-dimer 0.63* 0.61*
 (n = 35, 31) (0.47, 0.84) (0.48, 0.78)
Interleukin-6 0.77 0.89
 (n = 35, 32) (0.53, 1.14) (0.58, 1.36)
Fibrinogen 1.02 0.88*
 (n = 33, 30) (0.93, 1.13) (0.78, 0.99)
  1. * P < 0.05.